https://www.bccresearch.com/index/rss/code/biotechnologyhttps://www.bccresearch.com/public/public/images2017/logo.png https://www.bccresearch.com/index/rss/code/biotechnologyDNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.en-usN/Ainfo@bccresearch.com 30Copyright (C) 2022 bccresearch.comThe global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/cell-line-and-membrane.htmlThe global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/human-microbiome-diagnostics-market-report.htmlThe global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/microbiome-sequencing-market-report.htmlThe global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/proteomics-technologies-and-global-markets.htmlThe global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/biologic-therapeutic-drugs-technologies-markets-report.htmlThe global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/manufacturing-tech-protein-drugs-markets-report.htmlThe global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/GPCR-targeting-technology.htmlThe global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/2024-cell-and-gene-research-review.htmlThe global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/organ-on-a-chip-markets-research-report.htmlThe global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/single-cell-geomics-and-proteomics-markets-report.htmlThe global market for CAR T-cell therapy is expected to grow from $4.6 billion in 2024 and projected to reach $25.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 40.2% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/chimeric-antigen-receptor-car-t-cell-therapy-market-report.htmlThe global therapeutics for womenandrsquo;s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/therapeutics-womens-health-techs-markets-report.htmlThe global market for commercial amino acids is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/protein-synthesis-research-review.htmlThe global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/dna-and-rna-synthesis-research-market-review.htmlThe global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/global-markets-for-media-sera-and-reagents-in-biotechnology.htmlThe global market for enzymes in industrial applications is estimated to increase from $7.9 billion in 2024 to reach $10.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.5% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/global-markets-for-enzymes-in-industrial-applications.htmlThe global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/biosimilars-global-markets-report.htmlThe global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/diagnostics-market-research-review.htmlThe global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/cell-based-assays-technologies-markets-report.htmlThe global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/liquid-biopsy-research-tools-services-diagnostics.htmlThe global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/high-content-screening-imaging-technologies-and-global-markets.htmlThe global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/biomarkers-markets-report.htmlThe global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/bioprocess-optimization-and-digital-bio-manufacturing-global-markets.htmlThe global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/dna-sequencing-emerging-tech-applications-report.htmlThe global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/cancer-artificial-intelligence-market-report.htmlThe global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/cell-and-gene-therapy-market-tools-and-reagents.htmlThe global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/single-use-technologies-biopharmaceuticals-report.htmlThe global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/induced-pluripotent-stem-cells-report.htmlThe global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/commercial-amino-acids.htmlThe global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/ai-in-clinical-and-molecular-diagnostics-market.htmlThe global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/rna-sequencing-tech-markets-report.htmlThe global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/antibody-drugs-technologies-global-markets-report.htmlThe European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/life-science-tools-and-reagents-market.htmlThe global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/multiomics-market.htmlThe global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/drug-discovery-technologies-report.htmlThe global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/synthetic-biology-global-markets.htmlThe report provides an overview of current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/gene-editing-therapeutics-market.htmlThe global market for live cell imaging is expected to grow from $2.9 billion in 2024 and is projected to reach $4.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/live-cell-imaging-market.htmlThe global market for single-cell technologies is estimated to increase from $3.6 billion in 2023 to reach $9.2 billion by 2029, at a compound annual growth rate (CAGR) of 17.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/single-cell-market.htmlThe global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/artificial-intelligence-in-lifesciences-market.htmlThe global market for automated and closed cell therapy is expected to grow from $1.8 billion in 2024 and is projected to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.9% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/closed-and-automated-cell-therapy-market.htmlThe global market for theranostics was valued at $3.7 billion in 2023. The market is expected to grow from $4.3 billion in 2024 to $12.7 billion by the end of 2029, at a compound annual growth rate, or CAGR, of 24.0% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/theranostics-market-report.htmlThe global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/cell-therapy-biomanufacturing-market.htmlThe global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/single-nucleotide-polymorphism-genotyping-snp-report.htmlThe global market for in vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/in-vitro-diagnostics-ivd-quality-controls-market.htmlThe global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/life-science-tools-reagents-markets-report.htmlThe global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/rnai-technologies-markets.htmlThe global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/metabolomics.htmlThe global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/recombinant-proteins-market.htmlThe global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/biotechnology/polymerase-chain-reaction-pcr-for-point-of-care-poc-diagnostics.html